American ginseng (Panax quinquefolius L.) produces a number of saponins (ginsenosides). The ability of saponins from cultivated American ginseng to inhibit fungal growth in vitro was evaluated. Fungi exhibited a range of sensitivity to ginsenosides extracted from roots collected in two growing seasons. Important root pathogens (Cylindro carpon destructans, Fusarium solani, and Fusarium oxysporum) were unaffected by these phytochemicals at a concentration of 1 mg·mL1, whereas the growth of Alternaria panax and nonpathogenic Trichoderma spp. was inhibited. The same trend emerged when a range of ginsenoside concentrations was used on a subset of fungi. Hyphal growth of C. destructans was unaffected up to a level of ginsenosides approaching that found in roots (i.e., ~ 3% dry weight). The growth of F. solani was significantly less than that of the control at saponin concentrations of 0.1 to 3.0% (w/v), but was relatively unaffected in comparison to growth of Trichoderma hamatum and A. panax.
No takes yet. Share an insight, caveat, or question.
Nicol et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: